Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
Complete the form below to unlock access to ALL audio articles.
Biomoda, Inc. has announced a collaborative agreement with Medical Acoustics, LLC, to collect lung sputum samples in an upcoming clinical study that will use Biomoda's proprietary testing technology for detection of early lung cancer.
Biomoda's screening technology is designed to identify cancerous or aberrant cells extracted from samples of lung sputum; cancerous cells glow red under fluorescent light and can be detected under a microscope. Current diagnostic methods for lung cancer often detect the disease only at more advanced stages.
Medical Acoustics' Lung Flute® is a minimally invasive, flute-shaped device that uses low frequency sound waves to help patients with the natural mucus clearing system. When a patient exhales through the mouthpiece of the device, the exhalation generates specific sound waves that vibrate cilia and the airways, causing deep lung secretions to thin and be expelled by coughing. The FDA-cleared technology produces sputum samples without the need for saline induction.
The Lung Flute® will be used during an upcoming clinical program that will be administered by New Mexico Institute of Mining and Technology (New Mexico Tech) in partnership with the New Mexico Department of Veterans Services (DVS).
Biomoda will conduct the first year of the $350,000 clinical program, while New Mexico Tech and DVS will oversee the program and provide treatment to those veterans who test positive for lung cancer.
"The Lung Flute® presents a safe, effective, convenient and rapid method of sputum induction for patients participating in our veterans' clinical study for lung cancer," said Connie Dorian, Director of Technical Operations for Biomoda. "Sputum induction with the Lung Flute is safer, less time consuming, more convenient and better tolerated by patients than induction with hypertonic saline."
